Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin for Cognition in Schizophrenia
NCT00646581Phase 4Completed
- Sponsor
- University of Massachusetts
- Start
- Oct 2006
- Primary completion
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of regular human insulin in schizophrenia, schizoaffective disorder, sponsored by University of Massachusetts. Started Oct 2006; status: completed.
02
Drugs
regular human insulin
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00646581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00646581.